Experimental Study of Using Aloe Vera Gel to Treat Diabetic Chronic Cutaneous Ulcers in Bama Miniature Pigs

LIANG Yu-jie, LI Yan, GAO Yun-yi, WANG Li, RAN Xing-wu

Abstract

To investigate the efficacy, safety, and mechanism of topical application of aloe vera gel (AVG) to treat diabetic chronic cutaneous ulcers in Bama miniature pigs.   Methods   The Bama miniature pig model of diabetic chronic skin wounds was constructed and the model pigs were randomly assigned to AVG daily administration group (AVG QD), aloe vera gel every-other-day administration group (AVG QOD), and diabetic control group (DC). A non-diabetic chronic skin wounds model pig was set as the non-diabetic control group (NDC). Treatment efficacy was evaluated based on the amount of time needed for complete healing of the wounds, healing rates, granulation growth rates, and skin histopathological changes. Safety was evaluated according to whether adverse reactions were observed. In addition, the dynamic changes of the relative expression levels of miR21, miR29a, miR126, miR146a, miR155, and miR210 in wound granulation tissues were examined.   Results  1) Efficacy and safety: The amount of time needed for complete healing of the wounds was shorter in the NDC group than those of the three other groups, DC group, AVG QD group, and AVG QOD group (all P<0.05). The amount of time needed for complete healing of the wounds was shorter in the AVG QD group and AVG QOD group than that of DC group (all P<0.05). The amount of time needed for complete healing of the wounds was shorter in the AVG QOD group than that of AVG QD group (all P<0.05). No adverse reactions were detected in the whole process of AVG topical treatment. The granulation growth rate of NDC group was higher than those of DC group, AVG QD group, and AVG QOD group (all P<0.05). The wound healing rate of NDC group was higher than those of DC group, AVG QD group, and AVG QOD group (all P<0.05); the wound healing rate of AVG QOD group was higher than those of DC group and AVG QD group (all P<0.05). 2) Histopathology: The results of HE staining light microscopy showed that collagen fiber production increased, and that microvascular formation with slight inflammatory cell infiltration was observed in the dermal interstitium at the initial stage of wound healing after AVG treatment. One year of after complete healing, pathological examination results of wound healing skin showed that the epidermal keratinization was complete, that collagen was arranged neatly and orderly, and that many microvessels were found in the interstitium. The results of picric acid celestite scarlet staining showed that, after AVG treatment, type Ⅰ collagen mainly increased in the initial stage of wound healing, type Ⅲ collagen gradually increased when the wound healed completely, and the collagen was arranged neatly during the whole process. 3) The relative expression of microRNAs: The relative expression of miR21, miR126, and miR210 in NDC group, AVG QD group, and AVG QOD group were higher than that in DC group (all P<0.05). The relative expression of miR29a and miR155 in NDC group, AVG QD group, and AVG QOD group was lower than that in DC group (all P<0.05). The relative expression of miR146a in NDC group was higher than that in DC group (P<0.05).   Conclusion   AVG topical application can shorten the time needed for complete healing of diabetic chronic wounds in Bama minipigs. The wound healing speed of the alternate-day treatment group was faster than that of the daily treatment group. No adverse reactions were observed over the course of the treatment. The mechanism may be related to the up-regulation of the expressions of miR21, miR126, and miR210 and the down-regulation of miR29a and miR155 in wound granulation tissue.

 

Keywords: Aloe vera gel, Bama minipigs, Diabetes mellitus, Chronic cutaneous ulcer, microRNAs, Wound healing

 

Full Text:

PDF


References


XU Z， RAN X. Diabetic foot care in China: Challenges and strategy. Lancet Diabetes Endocrinol，2016，4(4): 297–298.

SURJUSHE A， VASANI R， SAPLE D G. Aloe vera: A short review. Indian J Dermatol，2008，53(4): 163–166.

WANG C H， CHANG S J， TZENG Y S， et al. Enhanced wound-healing performance of a phyto-polysaccharide-enriched dressing--A preclinical small and large animal study. Int Wound J，2017，14(6): 1359–1369.

NAJAFIAN Y， KHORASANI Z M， NAJAFI M N， et al. Efficacy of Aloe vera/plantago major gel in diabetic foot ulcer: A randomized double-blind clinical trial. Curr Drug Discov Technol，2019，16(2): 223–231.

IRANI P S， VARAIE S. Comparison of the effect of aloe vera gel and nitrofurazone 2% on epithelialization and granulation tissue formation regarding superficial second-degree burns. Iran J Med Sci，2016，41(3 Suppl): S3.

MOLAZEM Z， MOHSENI F， YOUNESI M， et al. Aloe vera gel and cesarean wound healing; A randomized controlled clinical trial. Glob J Health Sci，2014，7(1): 203–209.

HEKMATPOU D， MEHRABI F， RAHZANI K， et al. The effect of aloe vera gel on prevention of pressure ulcers in patients hospitalized in the orthopedic wards: A randomized triple-blind clinical trial. BMC Complement Altern Med，2018，18(1): 264.

BURUSAPAT C， SUPAWAN M， PRUKSAPONG C， et al. Topical aloe vera gel for accelerated wound healing of split-thickness skin graft donor sites: A double-blind, randomized, controlled trial and systematic review. Plast Reconstr Surg，2018，142(1): 217–226.

TONG X， LI M， LI D， et al. Aloe vera gel extract: Safety evaluation for acute and chronic oral administration in Sprague-Dawley rats and anticancer activity in breast and lung cancer cells. J Ethnopharmacol， 2021， 280: 114434[2022-08-01]. https://doi.org/10.1016/j.jep.2021. 114434.

GALLI C L， CINELLI S， CILIUTTI P， et al. Lack of in vivo genotoxic effect of dried whole Aloe ferox juice. Toxicol Rep，2021，8: 1471–1474.

WU J， ZHANG Y， LV Z， et al. Safety evaluation of Aloe vera soft capsule in acute， subacute toxicity and genotoxicity study. PLoS One， 2021， 16(3): e0249356[2022-08-01]. https://doi.org/10.1371/journal.pone. 0249356.

TANAKA M， MISAWA E， YAMAUCHI K， et al. Effects of plant sterols derived from Aloe vera gel on human dermal fibroblasts in vitro and on skin condition in Japanese women. Clin Cosmet Investig Dermatol，2015， 8: 95–104.

JETTANACHEAWCHANKIT S， SASITHANASATE S， SANGVANICH P， et al. Acemannan stimulates gingival fibroblast proliferation; expressions of keratinocyte growth factor-1, vascular endothelial growth factor, and type Ⅰ collagen; and wound healing. J Pharmacol Sci，2009， 109(4): 525–531.

PRAKOSO Y A， KURNIASIH. The Effects of Aloe vera Cream on the Expression of CD4+ and CD8+ Lymphocytes in Skin Wound Healing. J Trop Med， 2018， 2018: 6218303[2022-08-01]. https://doi.org/10.1155/ 2018/6218303.

TAKZAREE N， HADJIAKHONDI A， HASSANZADEH G， et al. Transforming growth factor-β (TGF-β) activation in cutaneous wounds after topical application of aloe vera gel. Can J Physiol Pharmacol，2016， 94(12): 1285–1290.

OZDEMIR D， FEINBERG M W. MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities. Trends Cardiovasc Med， 2019，29(3): 131–137.

LI D， LANDÉN N X. MicroRNAs in skin wound healing. Eur J Dermatol，2017，27(S1): 12–14.

SCHMITTGEN T D， LIVAK K J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc，2008，3(6): 1101–1108.

ATIBA A， WASFY T， ABDO W， et al. Aloe vera gel facilitates re-epithelialization of corneal alkali burn in normal and diabetic rats. Clin Ophthalmol，2015，9: 2019–2026.

GUPTA A， UPADHYAY N K， SAWHNEY R C， et al. A poly-herbal formulation accelerates normal and impaired diabetic wound healing. Wound Repair Regen，2008，16(6): 784–790.

DAS A， GANESH K， KHANNA S， et al. Engulfment of apoptotic cells by macrophages: A role of microRNA-21 in the resolution of wound inflammation. J Immunol，2014，192(3): 1120–1129.

YANG X， WANG J， GUO S L， et al. miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Biol Sci， 2011，7(5): 685–690.

ZHAO M. PTEN: A promising pharmacological target to enhance epithelial wound healing. Br J Pharmacol，2007，152(8): 1141–1144.

WANG J， QIU Y， SHI N W， et al. microRNA-21 mediates the TGF-β1-induced migration of keratinocytes via targeting PTEN. Eur Rev Med Pharmacol Sci，2016，20(18): 3748–3759.

MAURER B， STANCZYK J， JUNGEL A， et al. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum， 2010，62(6): 1733–1743.

CIECHOMSKA M， O'REILLY S， SUWARA M， et al. MiR-29a reduces TIMP-1 production by dermal fibroblasts via targeting TGF-beta activated kinase 1 binding protein 1， implications for systemic sclerosis. PLoS One， 2014， 9(12): e115596[2022-08-01]. https://doi.org/10.1371/journal.pone.0115596.


Refbacks

  • There are currently no refbacks.